Search tips
Search criteria 


Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. 1994 November; 62(11): 5195–5197.
PMCID: PMC303248

Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones.


The role of CD8+ T cells in antichlamydial immunity was investigated in a murine model of chlamydial genital infection by using T-cell clones generated against the Chlamydia trachomatis agent of mouse pneumonitis (MoPn). Two CD8+ T-cell clones tested (2.1F and 2.14-9) were chlamydia antigen specific and MHC restricted and reacted against MoPn as well as the Chlamydia psittaci agent of guinea pig inclusion conjunctivitis and C. trachomatis serovar E, suggesting the recognition of a genus-specific antigen. Upon adoptive transfer into persistently MoPn-infected nu/nu mice, 55.6% of the recipients of clone 2.1F (15 of 27) resolved the infection but recipients of clone 2.14-9 did not. The ability to resolve the MoPn infection correlated with the capacity of clone 2.1F to elaborate a combination of gamma interferon and tumor necrosis factor alpha. The results suggested that in addition to CD4+ T cells, CD8+ T cells may also contribute to antichlamydial T-cell immunity in vivo.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (613K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Buzoni-Gatel D, Guilloteau L, Bernard F, Bernard S, Chardès T, Rocca A. Protection against Chlamydia psittaci in mice conferred by Lyt-2+ T cells. Immunology. 1992 Oct;77(2):284–288. [PubMed]
  • Fraiz J, Jones RB. Chlamydial infections. Annu Rev Med. 1988;39:357–370. [PubMed]
  • Igietseme JU, Ramsey KH, Magee DM, Williams DM, Kincy TJ, Rank RG. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg Immunol. 1993 Nov-Dec;5(6):317–324. [PubMed]
  • Katz BP, Batteiger BE, Jones RB. Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis. Sex Transm Dis. 1987 Jul-Sep;14(3):160–164. [PubMed]
  • Kaufmann SH. CD8+ T lymphocytes in intracellular microbial infections. Immunol Today. 1988 Jun;9(6):168–174. [PubMed]
  • Kaufmann SH. Immunity to intracellular bacteria. Annu Rev Immunol. 1993;11:129–163. [PubMed]
  • Kupfer A, Singer SJ. Cell biology of cytotoxic and helper T cell functions: immunofluorescence microscopic studies of single cells and cell couples. Annu Rev Immunol. 1989;7:309–337. [PubMed]
  • Lammert JK. Cytotoxic cells induced after Chlamydia psittaci infection in mice. Infect Immun. 1982 Mar;35(3):1011–1017. [PMC free article] [PubMed]
  • Nabholz M, MacDonald HR. Cytolytic T lymphocytes. Annu Rev Immunol. 1983;1:273–306. [PubMed]
  • Nichols RL, Oertley RE, Fraser EC, MacDonald AB, McComb DE. Immunity to chlamydial infections of the eye. VI. Homologous neutralization of trachoma infectivity for the owl monkey conjuctivae by eye secretions from humans with trachoma. J Infect Dis. 1973 Apr;127(4):429–432. [PubMed]
  • Pavia CS, Schachter J. Failure to detect cell-mediated cytotoxicity against Chlamydia trachomatis-infected cells. Infect Immun. 1983 Mar;39(3):1271–1274. [PMC free article] [PubMed]
  • Qvigstad E, Hirschberg H. Lack of cell-mediated cytotoxicity towards Chlamydia trachomatis infected target cells in humans. Acta Pathol Microbiol Immunol Scand C. 1984 Jun;92(3):153–159. [PubMed]
  • Ramsey KH, Rank RG. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect Immun. 1991 Mar;59(3):925–931. [PMC free article] [PubMed]
  • Ramsey KH, Soderberg LS, Rank RG. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect Immun. 1988 May;56(5):1320–1325. [PMC free article] [PubMed]
  • Rank RG, Barron AL. Humoral immune response in acquired immunity to chlamydial genital infection of female guinea pigs. Infect Immun. 1983 Jan;39(1):463–465. [PMC free article] [PubMed]
  • Rank RG, Barron AL. Effect of antithymocyte serum on the course of chlamydial genital infection in female guinea pigs. Infect Immun. 1983 Aug;41(2):876–879. [PMC free article] [PubMed]
  • Rank RG, Batteiger BE, Soderberg LS. Susceptibility to reinfection after a primary chlamydial genital infection. Infect Immun. 1988 Sep;56(9):2243–2249. [PMC free article] [PubMed]
  • Rank RG, Batteiger BE, Soderberg LS. Immunization against chlamydial genital infection in guinea pigs with UV-inactivated and viable chlamydiae administered by different routes. Infect Immun. 1990 Aug;58(8):2599–2605. [PMC free article] [PubMed]
  • Rank RG, Soderberg LS, Barron AL. Chronic chlamydial genital infection in congenitally athymic nude mice. Infect Immun. 1985 Jun;48(3):847–849. [PMC free article] [PubMed]
  • Rank RG, Soderberg LS, Sanders MM, Batteiger BE. Role of cell-mediated immunity in the resolution of secondary chlamydial genital infection in guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun. 1989 Mar;57(3):706–710. [PMC free article] [PubMed]
  • Rank RG, White HJ, Barron AL. Humoral immunity in the resolution of genital infection in female guinea pigs infected with the agent of guinea pig inclusion conjunctivitis. Infect Immun. 1979 Nov;26(2):573–579. [PMC free article] [PubMed]
  • Romero P, Maryanski JL, Cordey AS, Corradin G, Nussenzweig RS, Zavala F. Isolation and characterization of protective cytolytic T cells in a rodent malaria model system. Immunol Lett. 1990 Aug;25(1-3):27–31. [PubMed]
  • Shemer-Avni Y, Wallach D, Sarov I. Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor. Infect Immun. 1988 Sep;56(9):2503–2506. [PMC free article] [PubMed]
  • Taguchi T, McGhee JR, Coffman RL, Beagley KW, Eldridge JH, Takatsu K, Kiyono H. Detection of individual mouse splenic T cells producing IFN-gamma and IL-5 using the enzyme-linked immunospot (ELISPOT) assay. J Immunol Methods. 1990 Mar 27;128(1):65–73. [PubMed]
  • Williams DM, Byrne GI, Grubbs B, Marshal TJ, Schachter J. Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice. Infect Immun. 1988 Nov;56(11):3004–3006. [PMC free article] [PubMed]
  • Williams DM, Magee DM, Bonewald LF, Smith JG, Bleicker CA, Byrne GI, Schachter J. A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect Immun. 1990 Jun;58(6):1572–1576. [PMC free article] [PubMed]
  • Zhang YX, Stewart S, Joseph T, Taylor HR, Caldwell HD. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol. 1987 Jan 15;138(2):575–581. [PubMed]
  • Zhong GM, Peterson EM, Czarniecki CW, de la Maza LM. Recombinant murine gamma interferon inhibits Chlamydia trachomatis serovar L1 in vivo. Infect Immun. 1988 Jan;56(1):283–286. [PMC free article] [PubMed]
  • Zhong GM, Peterson EM, Czarniecki CW, Schreiber RD, de la Maza LM. Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections. Infect Immun. 1989 Jan;57(1):152–157. [PMC free article] [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)